STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Milestone Pharmaceuticals (Nasdaq: MIST) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. President and CEO Joe Oliveto and Chief Commercial Officer Lorenz Muller will engage in a fireside chat on December 4, 2024, at 10:30 a.m. Eastern Time. The event will feature a live webcast available to conference participants. Interested parties can request access to the fireside chat or schedule meetings with the Milestone team by contacting corporateaccess@psc.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

MONTREAL and CHARLOTTE, N.C., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, and Chief Commercial Officer, Lorenz Muller, will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024, at 10:30 a.m. Eastern Time.

A live webcast of the fireside chat will be available to conference participants. If you are interested in viewing the fireside chat or meeting with the Milestone team during the conference, email corporateaccess@psc.com.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone's lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat episodic attacks associated with PSVT and AFib-RVR.

Contact:
Kim Fox,
Vice President, Communications,
kfox@milestonepharma.com

Investor Relations
Chris Calabrese, ccalabrese@lifesciadvisors.com

Kevin Gardner, kgardner@lifesciadvisors.com


FAQ

When is Milestone Pharmaceuticals (MIST) presenting at the Piper Sandler Healthcare Conference?

Milestone Pharmaceuticals will present at the Piper Sandler Healthcare Conference on December 4, 2024, at 10:30 a.m. Eastern Time.

Who will represent Milestone Pharmaceuticals (MIST) at the Piper Sandler Conference?

President and CEO Joe Oliveto and Chief Commercial Officer Lorenz Muller will represent Milestone Pharmaceuticals at the conference.

How can investors access Milestone Pharmaceuticals' (MIST) presentation at the Piper Sandler Conference?

Interested parties can email corporateaccess@psc.com to view the fireside chat or schedule meetings with the Milestone team.

What type of presentation will Milestone Pharmaceuticals (MIST) give at the Piper Sandler Conference?

Milestone Pharmaceuticals will participate in a fireside chat format presentation, which will be available via live webcast to conference participants.
Milestone Pharmaceuticals

NASDAQ:MIST

MIST Rankings

MIST Latest News

MIST Latest SEC Filings

MIST Stock Data

225.70M
78.88M
3.37%
20.09%
6.37%
Biotechnology
Pharmaceutical Preparations
Link
Canada
MONTREAL